TGINSIGHT SIMILAR POSTS
Source channel @githubtrending · Post #15212 · Oct 10
#typescript#agent#agent_platform#ai_plugins#chatbot#chatbot_framework#coze#coze_platform#generative_ai#go#kouzi#low_code_ai#multimodel_ai#no_code#rag#studio#typescript#workflow Coze Studio is an easy-to-use, all-in-one platform for building AI agents and apps without needing much coding. It offers visual tools to design, debug, and deploy AI projects quickly using drag-and-drop workflows, plugins, and large language models like GPT-4. You can create smart assistants, chatbots, or custom AI apps with ready templates and manage models, knowledge bases, and plugins in one place. It supports no-code and low-code development, making AI accessible to both beginners and professionals, saving you time and effort in building powerful AI solutions tailored to your needs. It also supports multi-model integration and easy deployment. https://github.com/coze-dev/coze-studio
Search: #biotechnology
@venturevillagewall · Post #3500 · 12/19/2024, 01:59 PM
Xcell Biosciences Secures $1.4M Xcell Biosciences has raised $1.40 million for advancing its cell therapy manufacturing. The funding round took place on December 17, 2024. Learn more at Xcell Biosciences #XcellBiosciences#Funding#CellTherapy#SanFrancisco#Biotechnology#HealthTech
@venturevillagewall · Post #3574 · 12/20/2024, 09:33 AM
Tessera Therapeutics Secures $50M Tessera Therapeutics has raised $50 million in funding on December 18, 2024. The early-stage life sciences company is at the forefront of Gene Writing™, a cutting-edge biotechnology aimed at transforming medicine and scientific research. More details available on their official website: Tessera Therapeutics #TesseraTherapeutics#Funding#LifeSciences#Biotechnology#GeneWriting#Healthcare#MedicalResearch
@venturevillagewall · Post #3627 · 12/21/2024, 10:22 AM
First Oral Diabetes Therapy Funded TIXiMED has raised $2.65 million to develop TXNIP inhibiting medication, targeting Type 1 and Type 2 Diabetes with an innovative oral therapeutic. Learn more about their project here. #TIXiMED#Diabetes#Funding#Healthcare#TXNIP#Therapeutics#Type1Diabetes#Type2Diabetes#Biotechnology
@venturevillagewall · Post #3582 · 12/20/2024, 09:34 AM
$140M Funding for Ottimo Pharma Ottimo Pharma announces a funding round of $140 million set for December 19, 2024. The company focuses on developing bi-functional medicines aimed at improving the lives of individuals living with cancer. Learn more #Funding#OttimoPharma#Cancer#BiFunctionalMedicines#Healthcare#Pharmaceuticals#LifeSciences#Investments#MedicalResearch#Oncology#HealthTech#Biotechnology
@venturevillagewall · Post #3557 · 12/20/2024, 09:32 AM
Spine BioPharma Raises $13.51M Spine BioPharma has successfully closed a funding round totaling $13.51 million, announced on December 18, 2024. For more details, visit their official site: Spine BioPharma. #SpineBioPharma#Funding#BioPharma#Investment#Healthcare#LifeSciences#VentureCapital#Startup#ClinicalTrials#MedicinalResearch#Pharma#Innovations#Tech#Biotechnology#Market#Earnings#Growth#Investors#Equity
@venturevillagewall · Post #3629 · 12/21/2024, 10:22 AM
$4.07M Funding for PeptiSystems PeptiSystems secured $4.07M in funding on December 20, 2024. The company develops advanced instruments for solid-phase synthesis in peptide and oligonucleotide therapeutics, catering to both GMP and non-GMP manufacturing. Discover more: PeptiSystems #Funding#PeptiSystems#Therapeutics#Peptides#Oligonucleotides#GMP#Manufacturing#Synthesis#Biotechnology#Pharmaceuticals#MedicalDevices#FlowthroughColumnTechnology#ProcessDevelopment#LifeSciences